Our products categories include an anti-Malarial brand, LUMALAR-CQ that comes in artemether (20mg)/lumefantrine (120mg) tablet formulation. LUMALAR-CQ is available in blister packs of x6s, x12s, x18s, and x24s. This product, which is a World Health Organization, WHO-recommended artemisinin-based combination therapy, ACT is indicated for the treatment of adult and pediatric patients with Malarial infections due to either plasmodium falciparum or the more resistant species, plasmodium vivax.

Our second product is an anti-Hepatitis brand, called TEXAVIR. This product, which contains active ingredients, tenofovir disoproxil fumarate is formulated in 300mg tablets a monotherapy used to treat Hepatitis B infection. TEXAVIR is recommended as a first line treatment by WHO and is available in packs of 30 tablets.